MHC
PFE icon

May Hill Capital’s Pfizer PFE Stock Holding History

May Hill Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$342K Buy
12,185
+2,997
+33% +$79.8K 0.09% 162
2025
Q4 		$229K Sell
9,188
-23
-0.2% -$580 0.06% 179
2025
Q3 		$235K Buy
+9,211
New +$227K 0.07% 170

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

May Hill Capital's PFE Position: Q1 2026 in Review

May Hill Capital increased its Pfizer (PFE) stake by 33% in Q1 2026, buying an estimated $79.8K and bringing the position to 12,185 shares worth $342K. The position accounts for 0.09% of the portfolio, ranked #162.

May Hill Capital first reported a position in PFE in Q3 2025 and has held it in 3 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • May Hill Capital held 12,185 shares of Pfizer worth $342K as of Q1 2026.
  • May Hill Capital bought 2,997 Pfizer shares in Q1 2026, an estimated $79.8K.
  • Pfizer made up 0.09% of May Hill Capital's portfolio in Q1 2026, its #162 holding.
  • May Hill Capital first reported a position in Pfizer in Q3 2025 and has held it in 3 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on May Hill Capital's 13F filing for Q1 2026, filed 6 May 2026.